Rationale and methodology of the I.C.A.I. study, a randomised clinical trial of alprostadil in the treatment of chronic critical leg ischemia

Journal of Nephrology

Volumn 9, Issue 2, 1996, Pages 93-98

  Tognoni, Gianni ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Critical leg ischemia; Prostanoids; Randomised clinical trial; Trial methodology

Indexed keywords

PROSTAVASIN;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 9044236163     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. European Working Group on Critical Limb Ischaemia. European Consensus on Critical Limb Ischaemia. Lancet 1989; 1: 737-8.
2. Dormandy J, ed. European Consensus Document on Critical Limb Ischaemia. Berlin: Springer-Verlag, 1989.
3. European Working Group on Critical Leg Ischaemia. Second European Consensus Document on Chronic Critical Leg Ischemia. Circulation 1991; 84 (Suppl IV): 1-26.
4. The i.c.a.i. group (gruppo di studio dell'ischemia cronica critica degli arti inferiori). A prospective epidemiological survey of the natural history of chronic critical leg ischaemia. Evidence of the severity of prognosis and need for large-scale clinical trials. Eur J Vasc Endovasc Surg 1996; 11: 112-20.
5. Verstraete M, Verhaeghe R. Primary pharmacotherapy other than prostanoids. In: Dormandy JA, Stock G, eds. Critical leg ischemia. Its pathophysiology and management. Berlin: Springer Verlag 1990; 99-113.
6. de Gaetano G, Cerletti C, Bertele' V. The use of prostanoids in critical leg ischaemia. Critical Ischaemia 1992; 2: 5-12.
7. Norgren L. Non-surgical treatment of critical limb ischaemia. Eur J Vas Surg 1990; 4: 449-54.
8. Diehm C, Abri O, Baitsch G, et al. Iloprost, ein stabiles Prostacyclinderivat, bei arterieller Verschlusskrankheit im Stadium IV. Eine placebo kontrollierte Multizenterstudie. Dtsch Med Wschr 1989; 114: 783-8.
9. Brock FE, Abri O, Baitsch G, et al. Iloprost in der Behandlung ischämischer Gewebsläsionen dei Diabetikern. Schweiz Med Wschr 1990; 120: 1477-82.
10. Norgren L, Alwmark A, Angqvist KA, et al. A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study. Eur J Vasc Surg 1990; 4: 463-7.
11. U.K. Severe Limb Ischaemia Study Group. Treatment of limb threatening ischaemia with intravenous iloprost: a randomised double-blind placebo controlled study. Eur J Vasc Surg 1991; 5: 511-6.
12. Guilmot JL, Diot E. Treatment of the lower limb ischaemia due to atherosclerosis in diabetic and nondiabetic patients with Iloprost, a stable analogue of prostacyclin. Results of a French Multicentre Trial. Drug Invest 1991; 3: 351-9.
13. Loosemore TM, Chalmers TC, Dormandy JA. A meta-analysis of randomized placebo control in Fontaine stages III and IV peripheral occlusive arterial disease. Int Angiol 1994; 13: 133-42.
14. 1 - Wirkungen und therapeutische Wirksamkeit. Berlin: Springer Verlag 1988; 133.
15. 1 versus pentoxifylline therapy in chronic arterial occlusive disease. A controlled randomised multicenter study. Vasa 1989; 28 (suppl): 44-9.